The Fredrickson classification organizes hyperlipidemias into distinct types based on which lipoprotein-processing step is disrupted and which lipoprotein consequently accumulates in the circulation, linking lipoprotein metabolism (chylomicron formation, VLDL-to-LDL conversion, and receptor-mediated clearance) to a specific pathological phenotype. Each type is defined by a discrete molecular defect—deficiency of an enzyme or cofactor, deficiency of a cell-surface receptor, or impaired removal of a metabolic intermediate—that determines which lipid species (triglycerides, LDL/cholesterol, or a combination) rises in the blood. This framework belongs to cardiovascular pathology and lipid metabolism, connecting biochemical lipoprotein transport pathways to clinical phenotypes and their pharmacological management.
The Fredrickson classification organizes hyperlipidemias into distinct types based on which lipoprotein-processing step is disrupted and which lipoprotein consequently accumulates in the circulation,…